|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0004048,
umls-concept:C0011860,
umls-concept:C0021641,
umls-concept:C0087111,
umls-concept:C0332307,
umls-concept:C0442027,
umls-concept:C0450442,
umls-concept:C0681850,
umls-concept:C1550501,
umls-concept:C1706203,
umls-concept:C2349001,
umls-concept:C2587213,
umls-concept:C2603343,
umls-concept:C2697811,
umls-concept:C2825951
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2006-8-21
|
|
pubmed:abstractText |
This controlled proof-of-concept study investigated inhaled insulin (INH) as adjunctive therapy to existing oral antidiabetic agents in subjects with type 2 diabetes.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
1462-8902
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
8
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
574-80
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:16918593-Administration, Inhalation,
pubmed-meshheading:16918593-Administration, Oral,
pubmed-meshheading:16918593-Adolescent,
pubmed-meshheading:16918593-Adult,
pubmed-meshheading:16918593-Blood Glucose,
pubmed-meshheading:16918593-Diabetes Mellitus, Type 2,
pubmed-meshheading:16918593-Drug Administration Schedule,
pubmed-meshheading:16918593-Drug Therapy, Combination,
pubmed-meshheading:16918593-Female,
pubmed-meshheading:16918593-Humans,
pubmed-meshheading:16918593-Hypoglycemic Agents,
pubmed-meshheading:16918593-Injections, Subcutaneous,
pubmed-meshheading:16918593-Insulin,
pubmed-meshheading:16918593-Insulin, Long-Acting,
pubmed-meshheading:16918593-Male,
pubmed-meshheading:16918593-Metformin,
pubmed-meshheading:16918593-Middle Aged,
pubmed-meshheading:16918593-Pilot Projects,
pubmed-meshheading:16918593-Sulfonylurea Compounds,
pubmed-meshheading:16918593-Treatment Failure
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Inhaled insulin as adjunctive therapy in subjects with type 2 diabetes failing oral agents: a controlled proof-of-concept study.
|
|
pubmed:affiliation |
Profil Institut für Stoffwechselforschung GmbH, Hellersbergstr. 9, Neuss, Germany.
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial
|
